These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1340 related articles for article (PubMed ID: 33302541)

  • 21. Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer's disease.
    Ruthirakuhan M; Herrmann N; Suridjan I; Abraham EH; Farber I; Lanctôt KL
    Expert Opin Pharmacother; 2016 Dec; 17(18):2417-2429. PubMed ID: 27825018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reducing Aβ load and tau phosphorylation: Emerging perspective for treating Alzheimer's disease.
    Kalra J; Khan A
    Eur J Pharmacol; 2015 Oct; 764():571-581. PubMed ID: 26209363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advancement in therapeutic strategies for Alzheimer's disease: Insights from clinical trials.
    Khan T; Waseem R; Shahid M; Ansari J; Ahanger IA; Hassan I; Islam A
    Ageing Res Rev; 2023 Dec; 92():102113. PubMed ID: 37918760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overcoming translational barriers impeding development of Alzheimer's disease modifying therapies.
    Golde TE
    J Neurochem; 2016 Oct; 139 Suppl 2(Suppl 2):224-236. PubMed ID: 27145445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disease modifying therapy for AD?
    Golde TE
    J Neurochem; 2006 Nov; 99(3):689-707. PubMed ID: 17076654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aging, cortical injury and Alzheimer's disease-like pathology in the guinea pig brain.
    Bates K; Vink R; Martins R; Harvey A
    Neurobiol Aging; 2014 Jun; 35(6):1345-51. PubMed ID: 24360504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alzheimer's Disease: Characterization of the Brain Sites of the Initial Tau Cytoskeletal Pathology Will Improve the Success of Novel Immunological Anti-Tau Treatment Approaches.
    Rüb U; Stratmann K; Heinsen H; Seidel K; Bouzrou M; Korf HW
    J Alzheimers Dis; 2017; 57(3):683-696. PubMed ID: 28269779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Key Peptides and Proteins in Alzheimer's Disease.
    Penke B; Bogár F; Paragi G; Gera J; Fülöp L
    Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacotherapeutic combinations for the treatment of Alzheimer's disease.
    Nagata T; Shinagawa S; Nakajima S; Noda Y; Mimura M
    Expert Opin Pharmacother; 2022 Apr; 23(6):727-737. PubMed ID: 35230200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on Alzheimer's Disease Therapy and Prevention Strategies.
    Graham WV; Bonito-Oliva A; Sakmar TP
    Annu Rev Med; 2017 Jan; 68():413-430. PubMed ID: 28099083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of TREM2 in Alzheimer's Disease and its Consequences on β- Amyloid, Tau and Neurofibrillary Tangles.
    Singh AK; Mishra G; Maurya A; Awasthi R; Kumari K; Thakur A; Rai A; Rai GK; Sharma B; Kulkarni GT; Singh SK
    Curr Alzheimer Res; 2019; 16(13):1216-1229. PubMed ID: 31481003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current thinking on the mechanistic basis of Alzheimer's and implications for drug development.
    Ising C; Stanley M; Holtzman DM
    Clin Pharmacol Ther; 2015 Nov; 98(5):469-71. PubMed ID: 26250900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent Updates on the Development of Therapeutics for the Targeted Treatment of Alzheimer's Disease.
    Rajput S; Malviya R; Bahadur S; Puri D
    Curr Pharm Des; 2023; 29(35):2802-2813. PubMed ID: 38018199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ratio Aβ1-42:p-Tau: a Possible Diagnostic Tool in Differentiating Dementias.
    De Riva V; Galloni E; Lealini B; Zarantonello G; Disco C; Dionisio LD; Meligrana L; Marcon M; Perini F
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's disease-like perturbations in HIV-mediated neuronal dysfunctions: understanding mechanisms and developing therapeutic strategies.
    Jha NK; Sharma A; Jha SK; Ojha S; Chellappan DK; Gupta G; Kesari KK; Bhardwaj S; Shukla SD; Tambuwala MM; Ruokolainen J; Dua K; Singh SK
    Open Biol; 2020 Dec; 10(12):200286. PubMed ID: 33352062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Connecting the Dots: Linking the Biochemical to Morphological Transitions in Alzheimer's Disease.
    Baig AM
    ACS Chem Neurosci; 2019 Jan; 10(1):21-24. PubMed ID: 30160095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. D-ribose and pathogenesis of Alzheimer's disease.
    Javed M; Ahmad MI; Javed H; Naseem S
    Mol Biol Rep; 2020 Mar; 47(3):2289-2299. PubMed ID: 31933261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of tau protein in Alzheimer's disease: The prime pathological player.
    Muralidar S; Ambi SV; Sekaran S; Thirumalai D; Palaniappan B
    Int J Biol Macromol; 2020 Nov; 163():1599-1617. PubMed ID: 32784025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene therapy: an alternative to treat Alzheimer's disease.
    Doshi V; Joshi G; Sharma S; Choudhary D
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3675-3693. PubMed ID: 38078920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroimaging in dementia: in vivo amyloid imaging.
    Suhara T; Higuchi M; Miyoshi M
    Tohoku J Exp Med; 2008 Jun; 215(2):119-24. PubMed ID: 18577840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 67.